Biomedical research at Oslo University Hospital

Oslo University Hospital is a merger of three former university hospitals in Oslo. Biomedical research is one of the hospital's core activities. Research at the hospital is closely interlinked with research undertaken at the University of Oslo. More than 50% of all biomedical research in Norway is published by researchers affiliated with the hospital. Research undertaken cover both basic research, translational research, and clinical research.

Oslo University Hospital has a central role in developing and supporting biomedical research within the South-Eastern Regional Health Authority. The hospital also pursues international research collaborations.

Click here to see hierarchical division and subunit overview

Summary of publications:

Publications (original articles or review articles) published in 2017 from OUS - Addiction Treatment Research Units

9 publications found

Bukten A, Stavseth MR, Skurtveit S, Tverdal A, Strang J, Clausen T (2017)
High risk of overdose death following release from prison: variations in mortality during a 15-year observation period
Addiction, 112 (8), 1432-1439
DOI 10.1111/add.13803, PubMed 28319291

Fosen JT, Morini L, Sempio C, Giarratana N, Enger A, Mørland J, Høiseth G (2017)
Ethyl Glucuronide Elimination Kinetics in Fingernails and Comparison to Levels in Hair
Alcohol Alcohol, 52 (5), 580-586
DOI 10.1093/alcalc/agx035, PubMed 28591773

Hagen E, Erga AH, Hagen KP, Nesvåg SM, McKay JR, Lundervold AJ, Walderhaug E (2017)
One-year sobriety improves satisfaction with life, executive functions and psychological distress among patients with polysubstance use disorder
J Subst Abuse Treat, 76, 81-87
DOI 10.1016/j.jsat.2017.01.016, PubMed 28159440

Hagen E, Erga AH, Nesvåg SM, McKay JR, Lundervold AJ, Walderhaug E (2017)
One-year abstinence improves ADHD symptoms among patients with polysubstance use disorder
Addict Behav Rep, 6, 96-101
DOI 10.1016/j.abrep.2017.08.005, PubMed 29450242

Kjoesnes R, Waal H, Hauff E, Gossop M (2017)
Severe trauma among substance users in opioid maintenance treatment: users' assessment of worst trauma and clinical assessment of PTSD
Heroin Addict. Relat. Clin. Probl., 19 (1), 5-11

Madah-Amiri D, Clausen T, Lobmaier P (2017)
Rapid widespread distribution of intranasal naloxone for overdose prevention
Drug Alcohol Depend, 173, 17-23
DOI 10.1016/j.drugalcdep.2016.12.013, PubMed 28182982

Nyhagen HT, Waal H (2017)
The ageing OMT patient
Nord. Stud. Alcohol Drugs, 34 (1), 72-79

Tanum L, Solli KK, Latif ZE, Benth JŠ, Opheim A, Sharma-Haase K, Krajci P, Kunøe N (2017)
Effectiveness of Injectable Extended-Release Naltrexone vs Daily Buprenorphine-Naloxone for Opioid Dependence: A Randomized Clinical Noninferiority Trial
JAMA Psychiatry, 74 (12), 1197-1205
DOI 10.1001/jamapsychiatry.2017.3206, PubMed 29049469

Wright N, Reimer J, Somaini L, Roncero C, Maremmani I, Simon N, Krajci P, Littlewood R, D'Agnone O, Alho H, Rolland B (2017)
Are we ready to treat hepatitis C virus in individuals with opioid use disorder: assessment of readiness in European countries on the basis of an expert-generated model
Eur J Gastroenterol Hepatol, 29 (11), 1206-1214
DOI 10.1097/MEG.0000000000000962, PubMed 28914697

 
Page visits: 351481